Pathogenesis of hepatitis B virus infection
Open accessThe DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Abstract
The adaptive immune response is thought to be responsible for viral clearance and disease pathogenesis during hepatitis B virus infection. It is generally acknowledged that the humoral antibody response contributes to the clearance of circulating virus particles and the prevention of viral spread within the host while the cellular immune response eliminates infected cells. The T cell response to the hepatitis B virus (HBV) is vigorous, polyclonal and multispecific in acutely infected patients who successfully clear the virus and relatively weak and narrowly focussed in chronically infected patients, suggesting that clearance of HBV is T cell dependent. The pathogenetic and antiviral potential of the cytotoxic T lymphocyte (CTL) response to HBV has been proven by the induction of a severe necroinflammatory liver disease following the adoptive transfer of HBsAg specific CTL into HBV transgenic mice. Remarkably, the CTLs also purge HBV replicative intermediates from the liver by secreting type 1 inflammatory cytokines thereby limiting virus spread to uninfected cells and reducing the degree of immunopathology required to terminate the infection. Persistent HBV infection is characterized by a weak adaptive immune response, thought to be due to inefficient CD4+ T cell priming early in the infection and subsequent development of a quantitatively and qualitatively ineffective CD8+ T cell response. Other factors that could contribute to viral persistence are immunological tolerance, mutational epitope inactivation, T cell receptor antagonism, incomplete down-regulation of viral replication and infection of immunologically privileged tissues. However, these pathways become apparent only in the setting of an ineffective immune response which is, therefore, the fundamental underlying cause. Persistent infection is characterized by chronic liver cell injury, regeneration, inflammation, widespread DNA damage, and insertional deregulation of cellular growth control genes which, collectively, lead to cirrhosis of the liver and hepatocellular carcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepatitis B Virus Infection — Natural History and Clinical Consequences
Ganem, D., & Prince, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031087 · Cited by 2,357
Hepatitis B Virus Immunopathogenesis
Chisari, F. V. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.29 · Cited by 1,609
Self-citationSeeger, C., & Mason, W. S. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.1.51-68.2000 · Cited by 1,451
Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection
Guidotti, L. G., Rochford, R., Chung, J., Shapiro, M., Purcell, R., & Chisari, F. V. (1999) · Science · doi:10.1126/science.284.5415.825 · Cited by 1,223
Self-citationGenomic analysis of the host response to hepatitis C virus infection
Su, A. I., Pezacki, J. P., Wodicka, L., Brideau, A. D., Supekova, L., Thimme, R., Wieland, S., Bukh, J., Purcell, R. H., Schultz, P. G., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202608199 · Cited by 1,161
Self-citationIntracellular Inactivation of the Hepatitis B Virus by Cytotoxic T Lymphocytes
Guidotti, L. G., Ishikawa, T., Hobbs, M. V., Matzke, B., Schreiber, R., & Chisari, F. V. (1996) · Immunity · doi:10.1016/s1074-7613(00)80295-2 · Cited by 1,083
Self-citationSurvival and Causes of Death in Cirrhotic and in Noncirrhotic Patients with Primary Hemochromatosis
Niederau, C., Fischer, R., Sonnenberg, A., Stremmel, W., Trampisch, H. J., & Strohmeyer, G. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511143132004 · Cited by 1,069
Thimme, R., Wieland, S., Steiger, C., Ghrayeb, J., Reimann, K. A., Purcell, R. H., & Chisari, F. V. (2003) · Journal of Virology · doi:10.1128/jvi.77.1.68-76.2003 · Cited by 979
Self-citationRehermann, B., Ferrari, C., Pasquinelli, C., & Chisari, F. V. (1996) · Nature Medicine · doi:10.1038/nm1096-1104 · Cited by 854
Self-citationIMMUNOBIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS
Guidotti, L. G., & Chisari, F. V. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100230 · Cited by 811
Self-citationMaini, M. K., Boni, C., Lee, C. K., Larrubia, J. R., Reignat, S., Ogg, G. S., King, A. S., Herberg, J., Gilson, R., Alisa, A., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.8.1269 · Cited by 800
Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice
Chisari, F. V., Klopchin, K., Moriyama, T., Pasquinelli, C., Dunsford, H. A., Sell, S., Pinkert, C. A., Brinster, R. L., & Palmiter, R. D. (1989) · Cell · doi:10.1016/0092-8674(89)90770-8 · Cited by 697
Self-citationHepatic T cells and liver tolerance
Crispe, I. N. (2003) · Nature Reviews Immunology · doi:10.1038/nri981 · Cited by 661
Genomic analysis of the host response to hepatitis B virus infection
Wieland, S., Thimme, R., Purcell, R. H., & Chisari, F. V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401771101 · Cited by 652
Self-citationHigh-level hepatitis B virus replication in transgenic mice
Guidotti, L. G., Matzke, B., Schaller, H., & Chisari, F. V. (1995) · Journal of Virology · doi:10.1128/jvi.69.10.6158-6169.1995 · Cited by 642
Self-citationSamuel, C. E. (1991) · Virology · doi:10.1016/0042-6822(91)90112-o · Cited by 602
Natural Killer T Cell Activation Inhibits Hepatitis B Virus Replication in Vivo
Kakimi, K., Guidotti, L. G., Koezuka, Y., & Chisari, F. V. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.921 · Cited by 584
Self-citationIs a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?
Milich, D. R., Jones, J. E., Hughes, J. L., Price, J., Raney, A. K., & McLachlan, A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6599 · Cited by 580
Risk of Cirrhosis and Primary Liver Cancer in Alpha1-Antitrypsin Deficiency
Eriksson, S., Carlson, J., & Velez, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603203141202 · Cited by 580
Ferrari, C., Penna, A., Bertoletti, A., Valli, A., Antoni, A. D., Giuberti, T., Cavalli, A., Petit, M. A., & Fiaccadori, F. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.10.3442 · Cited by 505
Rehermann, B., Fowler, P., Sidney, J., Person, J., Redeker, A., Brown, M., Moss, B., Sette, A., & Chisari, F. V. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.1047 · Cited by 492
Self-citationMobilizing Dendritic Cells for Tolerance, Priming, and Chronic Inflammation
Sallusto, F., & Lanzavecchia, A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.4.611 · Cited by 467
Stealth and Cunning: Hepatitis B and Hepatitis C Viruses
Wieland, S. F., & Chisari, F. V. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9369-9380.2005 · Cited by 457
Self-citationHBV X Protein Alters the DNA Binding Specificity of CREB and ATF-2 by Protein-Protein Interactions
Maguire, H. F., Hoeffler, J. P., & Siddiqui, A. (1991) · Science · doi:10.1126/science.1827531 · Cited by 454
Woodchuck hepatitis virus X protein is required for viral infection in vivo
Zoulim, F., Saputelli, J., & Seeger, C. (1994) · Journal of Virology · doi:10.1128/jvi.68.3.2026-2030.1994 · Cited by 453
Toll-Like Receptor Signaling Inhibits Hepatitis B Virus Replication In Vivo
Isogawa, M., Robek, M. D., Furuichi, Y., & Chisari, F. V. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.7269-7272.2005 · Cited by 442
Self-citationDNA Microarray Analysis of Chimpanzee Liver during Acute Resolving Hepatitis C Virus Infection
Bigger, C. B., Brasky, K. M., & Lanford, R. E. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.7059-7066.2001 · Cited by 442
Pathogenesis of hepatitis B virus—related hepatocellular carcinoma: Old and new paradigms
Bréchot, C. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.016 · Cited by 438
Guidotti, L. G., Ando, K., Hobbs, M. V., Ishikawa, T., Runkel, L., Schreiber, R. D., & Chisari, F. V. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3764 · Cited by 412
Self-citationWild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis.
Brunetto, M. R., Giarin, M. M., Oliveri, F., Chiaberge, E., Baldi, M., Alfarano, A., Serra, A., Saracco, G. M., Verme, G., & Will, H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4186 · Cited by 399
Webster, G. J. M., Reignat, S., Brown, D., Ogg, G. S., Jones, L., Seneviratne, S. L., Williams, R., Dusheiko, G., & Bertoletti, A. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5707-5719.2004 · Cited by 387
Immune Pathogenesis of Hepatocellular Carcinoma
Nakamoto, Y., Guidotti, L. G., Kuhlen, C. V., Fowler, P., & Chisari, F. V. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.341 · Cited by 373
Self-citationHepatitis B virus transactivator HBx uses a tumour promoter signalling pathway
Kekulé, A. S., Lauer, U., Weiss, L., Luber, B., & Hofschneider, P. H. (1993) · Nature · doi:10.1038/361742a0 · Cited by 369
Immunobiology and Pathogenesis of Hepatocellular Injury in Hepatitis B Virus Transgenic Mice
Moriyama, T., Guilhot, S., Klopchin, K., Moss, B., Pinkert, C. A., Palmiter, R. D., Brinster, R. L., Kanagawa, O., & Chisari, F. V. (1990) · Science · doi:10.1126/science.1691527 · Cited by 366
Self-citationMaini, M. K., Boni, C., Ogg, G. S., King, A. S., Reignat, S., Lee, C. K., Larrubia, J. R., Webster, G. J. M., McMichael, A. J., Ferrari, C., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70289-1 · Cited by 366
Penna, A., Chisari, F. V., Bertoletti, A., Missale, G., Fowler, P., Giuberti, T., Fiaccadori, F., & Ferrari, C. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.6.1565 · Cited by 365
Self-citationChisari, F. V., Filippi, P., Buras, J., McLachlan, A., Popper, H., Pinkert, C. A., Palmiter, R. D., & Brinster, R. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6909 · Cited by 355
Self-citationPaterlini-Bréchot, P., Saigo, K., Murakami, Y., Chami, M., Gozuacik, D., Mugnier, C., Lagorce, D., & Bréchot, C. (2003) · Oncogene · doi:10.1038/sj.onc.1206492 · Cited by 354
Boni, C., Penna, A., Ogg, G. S., Bertoletti, A., Pilli, M., Cavallo, C., Cavalli, A., Urbani, S., Boehme, R., Panebianco, R., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.23045 · Cited by 339
Murakami, Y., Saigo, K., Takashima, H., Minami, M., Okanoue, T., Bréchot, C., & Paterlini-Bréchot, P. (2005) · Gut · doi:10.1136/gut.2004.054452 · Cited by 331
Nayersina, R., Fowler, P., Guilhot, S., Missale, G., Cerny, A., Schlicht, H. J., Vitiello, A., Chesnut, R., Person, J. L., Redeker, A. G., et al. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.10.4659 · Cited by 330
Self-citationThe size of the viral inoculum contributes to the outcome of hepatitis B virus infection
Asabe, S., Wieland, S. F., Chattopadhyay, P. K., Roederer, M., Engle, R. E., Purcell, R. H., & Chisari, F. V. (2009) · Journal of Virology · doi:10.1128/jvi.00867-09 · Cited by 320
Self-citationHagen, T. M., Huang, S., Curnutte, J., Fowler, P., Martinez, V, Wehr, C. M., Ames, B. N., & Chisari, F. V. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12808 · Cited by 311
Self-citationViruses, Immunity, and Cancer: Lessons from Hepatitis B
Chisari, F. V. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64980-2 · Cited by 304
Self-citationBertoletti, A., Ferrari, C., Fiaccadori, F., Penna, A., Margolskee, R., Schlicht, H. J., Fowler, P., Guilhot, S., & Chisari, F. V. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10445 · Cited by 301
Self-citationA Transgenic Mouse Model of the Chronic Hepatitis B Surface Antigen Carrier State
Chisari, F. V., Pinkert, C. A., Milich, D. R., Filippi, P., McLachlan, A., Palmiter, R. D., & Brinster, R. L. (1985) · Science · doi:10.1126/science.3865369 · Cited by 290
Self-citationHigh-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice
Koike, K., Moriya, K., Iino, S., Yotsuyanagi, H., Endo, Y., Miyamura, T., & Kurokawa, K. (1994) · Hepatology · doi:10.1002/hep.1840190403 · Cited by 287
Live recombinant vaccinia virus protects chimpanzees against hepatitis B
Moss, B., Smith, G. L., Gerin, J. L., & Purcell, R. H. (1984) · Nature · doi:10.1038/311067a0 · Cited by 281
Chisari, F. V., Filippi, P., McLachlan, A., Milich, D. R., Riggs, M., Lee, S., Palmiter, R. D., Pinkert, C. A., & Brinster, R. L. (1986) · Journal of Virology · doi:10.1128/jvi.60.3.880-887.1986 · Cited by 269
Self-citationHepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis
Kremsdorf, D., Soussan, P., Paterlini-Brechot, P., & Brechot, C. (2006) · Oncogene · doi:10.1038/sj.onc.1209559 · Cited by 269
Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies
Steinman, R. M., Inaba, K., Turley, S., Pierre, P., & Mellman, I. (1999) · Human Immunology · doi:10.1016/s0198-8859(99)00030-0 · Cited by 259
McClary, H., Koch, R., Chisari, F. V., & Guidotti, L. G. (2000) · Journal of Virology · doi:10.1128/jvi.74.5.2255-2264.2000 · Cited by 255
Self-citationWieland, S. F., Guidotti, L. G., & Chisari, F. V. (2000) · Journal of Virology · doi:10.1128/jvi.74.9.4165-4173.2000 · Cited by 243
Self-citationChen, M. T., Billaud, J.-N., Sällberg, M., Guidotti, L. G., Chisari, F. V., Jones, J., Hughes, J., & Milich, D. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406282101 · Cited by 241
Self-citationFerber, M. J., Montoya, D. P., Yu, C., Aderca, I., McGee, A., Thorland, E. C., Nagorney, D. M., Gostout, B. S., Burgart, L. J., Boix, L., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206528 · Cited by 238
Missale, G., Redeker, A., Person, J., Fowler, P., Guilhot, S., Schlicht, H. J., Ferrari, C., & Chisari, F. V. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.3.751 · Cited by 234
Self-citationHepatitis B Virus X Protein Is both a Substrate and a Potential Inhibitor of the Proteasome Complex
Hu, Z., Zhang, Z., Doo, E., Coux, O., Goldberg, A. L., & Liang, T. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7231-7240.1999 · Cited by 232
Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees
Wieland, S. F., Spangenberg, H. C., Thimme, R., Purcell, R. H., & Chisari, F. V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308478100 · Cited by 219
Self-citationEscaping High Viral Load Exhaustion
Reignat, S., Webster, G. J. M., Brown, D., Ogg, G. S., King, A., Seneviratne, S. L., Dusheiko, G., Williams, R., Maini, M. K., & Bertoletti, A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011723 · Cited by 218
Gene expression during the priming phase of liver regeneration after partial hepatectomy in mice
Su, A. I., Guidotti, L. G., Pezacki, J. P., Chisari, F. V., & Schultz, P. G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122359899 · Cited by 214
Self-citationClass I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo.
Ando, K., Guidotti, L. G., Wirth, S., Ishikawa, T., Missale, G., Moriyama, T., Schreiber, R. D., Schlicht, H. J., Huang, S. N., & Chisari, F. V. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.7.3245 · Cited by 201
Self-citationGuidotti, L. G., Borrow, P., Hobbs, M. V., Matzke, B., Gresser, I., Oldstone, M. B., & Chisari, F. V. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4589 · Cited by 201
Self-citationHepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice.
Dunsford, H. A., Sell, S., & Chisari, F. V. (1990) · PubMed · Cited by 198
Self-citationIntegration of hepatitis B virus DNA and its implications for hepatocarcinogenesis.
Matsubara, K., & Tokino, T. (1990) · PubMed · Cited by 193
Oscillating CD8+ T Cell Effector Functions after Antigen Recognition in the Liver
Isogawa, M., Furuichi, Y., & Chisari, F. V. (2005) · Immunity · doi:10.1016/j.immuni.2005.05.005 · Cited by 186
Self-citationWieland, S. F., Eustaquio, A., Whitten-Bauer, C., Boyd, B., & Chisari, F. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504273102 · Cited by 168
Self-citationRole of primary intrahepatic T‐cell activation in the ‘liver tolerance effect’
Bertolino, P., McCaughan, G. W., & Bowen, D. G. (2002) · Immunology and Cell Biology · doi:10.1046/j.0818-9641.2001.01048.x · Cited by 167
Specific mutations of hepatitis B virus in plasma predict liver cancer development
Kuang, S.-Y., Jackson, P. E., Wang, J.-B., Lu, P.-X., Muñoz, A., Qian, G.-S., Kensler, T. W., & Groopman, J. D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308232100 · Cited by 165
Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B
Jung, M.-C., Spengler, U., Schraut, W., Hoffmann, R., Zachoval, R., Eisenburg, J., Eichenlaub, D., Riethmüller, G., Paumgartner, G., Ziegler-Heitbrock, H. W. L., et al. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90074-l · Cited by 162
The Hepatitis B Virus Large Surface Protein (LHBs) Is a Transcriptional Activator
Hildt, E., Saher, G., Bruss, V., & HOFSCHNEIDER, P. H. (1996) · Virology · doi:10.1006/viro.1996.0594 · Cited by 151
Caselmann, W., Meyer, M. S., Kekulé, A. S., Lauer, U. M., HOFSCHNEIDER, P. H., & Koshy, R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.8.2970 · Cited by 146
Cavanaugh, V. J., Guidotti, L. G., & Chisari, F. V. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.2630-2637.1998 · Cited by 145
Self-citationNatoli, G., Avantaggiati, M. L., Chirillo, P., Costanzo, A., Artini, M., Balsano, C., & Levrero, M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.989 · Cited by 144
Lieber, C. S., Garro, A. J., Leo, M. A., Mak, K. M., & Worner, T. M. (1986) · Hepatology · doi:10.1002/hep.1840060533 · Cited by 143
Tsui, L. V., Guidotti, L. G., Ishikawa, T., & Chisari, F. V. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12398 · Cited by 132
Self-citationHuang, S.-N., & Chisari, F. V. (1995) · Hepatology · doi:10.1002/hep.1840210303 · Cited by 119
Self-citationWieland, S. F., Vega, R. G., Müller, R., Evans, C. F., Hilbush, B. S., Guidotti, L. G., Sutcliffe, J. G., Schultz, P. G., & Chisari, F. V. (2002) · Journal of Virology · doi:10.1128/jvi.77.2.1227-1236.2003 · Cited by 111
Self-citationPathogenetic effector function of CD4-positive T helper 1 cells in hepatitis B virus transgenic mice
Franco, A., Guidotti, L. G., Hobbs, M. V., Pasquetto, V., & Chisari, F. V. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.4.2001 · Cited by 107
Self-citationIntrahepatic T Cells in Hepatitis B
Rehermann, B. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.8.1263 · Cited by 107
Heise, T., Guidotti, L. G., Cavanaugh, V. J., & Chisari, F. V. (1999) · Journal of Virology · doi:10.1128/jvi.73.1.474-481.1999 · Cited by 103
Self-citationcis-Activation of the Human Telomerase Gene (hTERT) by the Hepatitis B Virus Genome
Horikawa, I., & Barrett, J. C. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.15.1171 · Cited by 96
La Autoantigen Specifically Recognizes a Predicted Stem-Loop in Hepatitis B Virus RNA
Heise, T., Guidotti, L. G., & Chisari, F. V. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5767-5776.1999 · Cited by 94
Self-citationMinami, M., Daimon, Y., Mori, K., Takashima, H., Nakajima, T., Itoh, Y., & Okanoue, T. (2005) · Oncogene · doi:10.1038/sj.onc.1208628 · Cited by 91
Inhibition of Hepatitis B Virus Replication by Interferon Requires Proteasome Activity†
Robek, M. D., Wieland, S. F., & Chisari, F. V. (2002) · Journal of Virology · doi:10.1128/jvi.76.7.3570-3574.2002 · Cited by 85
Self-citationHepatocellular carcinoma in primary biliary cirrhosis: Detection by α-fetoprotein estimation
Melia, W. M., Johnson, P. J., Neuberger, J., Zaman, S. N., Portmann, B. G., & Williams, R. L. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90540-7 · Cited by 83
Iavarone, M. A., Trabut, J., Delpuech, O., Carnot, F., Colombo, M., Kremsdorf, D., Bréchot, C., & Thiers, V. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00217-4 · Cited by 80
Human Class I Supertypes and CTL Repertoires Extend to Chimpanzees
Bertoni, R., Sette, A., Sidney, J., Guidotti, L. G., Shapiro, M., Purcell, R. H., & Chisari, F. V. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.4447 · Cited by 76
Self-citationHeise, T., Guidotti, L. G., & Chisari, F. V. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.6874-6883.2001 · Cited by 70
Self-citationHost–Virus Interactions during Malaria Infection in Hepatitis B Virus Transgenic Mice
Pasquetto, V., Guidotti, L. G., Kakimi, K., Tsuji, M., & Chisari, F. V. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.529 · Cited by 69
Self-citationInhibition of Hepatitis B Virus Replication during Schistosoma mansoni Infection in Transgenic Mice
McClary, H., Koch, R. J., Chisari, F. V., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.289 · Cited by 38
Self-citationThimme, R., Chang, K., Pemberton, J., Sette, A., & Chisari, F. V. (2001) · Journal of Virology · doi:10.1128/jvi.75.8.3984-3987.2001 · Cited by 31
Self-citation
Cited by
HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B
Nassal, M. (2015) · Gut · doi:10.1136/gutjnl-2015-309809 · Cited by 899
Lanford, R. E., Guerra, B., Chavez, D., Giavedoni, L., Hodara, V. L., Brasky, K. M., Fosdick, A., Frey, C. R., Zheng, J., Wolfgang, G., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.003 · Cited by 377
Lipid nanoparticle technology for therapeutic gene regulation in the liver
Witzigmann, D., Kulkarni, J. A., Leung, J., Chen, S., Cullis, P. R., & van der Meel, R. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.026 · Cited by 376
Immune responses and immunopathology in acute and chronic viral hepatitis
Shin, E.-C., Sung, P. S., & Park, S.-H. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.69 · Cited by 365
Immune Responses to HCV and Other Hepatitis Viruses
Park, S.-H., & Rehermann, B. (2014) · Immunity · doi:10.1016/j.immuni.2013.12.010 · Cited by 265
Metadata
- Authors
- Chisari, F. V., Isogawa, M., & Wieland., S. F.
- Venue
- Pathologie Biologie
- Publisher
- Elsevier BV
- Published
- 2010-08
- Volume
- 58
- Issue
- 4
- Pages
- 258-266
- ISSN
- 0369-8114 (ISSN-L)
- OpenAlex
- W2011555137
- Cited by
- 414
- References
- 91
- FWCI
- 16.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.